HNMPA 是一种胰岛素受体酪氨酸激酶抑制剂，可抑制人源胰岛素受体的丝氨酸和酪氨酸自磷酸化。

HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.

HNMPA reduces neuronal firing after GABA application and blocks GABA-dependent insulin inhibition[1]. HNMPA has no effect on cyclic AMP-dependent protein kinase or protein kinase C activities[2].

132541-52-7

C11H11O4P

238.18

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years